Abstract:OBJECTIVE:To investigate the effect of small interfering RNA (siRNA) targeting human vascular endothelial growth factor (hVEGF) on A549 cell growth in nude mice and angiogenesis on chorioallantoic membrane (CAM) assay.METHODS:Three pairs of hVEGF siRNA-plasmid and non-silencing-plasmid were constructed, and transfected into A549 cells through lipofectamine 2000, respectively. The most effective pair of hVEGF siRNA-plasmid was selected by ELISA and real-time RT-PCR. A549 cells transfected with selected hVEGF siRNA- plasmid, A549 cells transfected with non-silencing-plasmid and A549 cells without transfection were inoculated into nude mice, respectively. Chick embryos were randomly divided into four groups and CAM was treated by different solutions for 48 h: culture media DMEM as negative control group,un-transfected A549 cell culture supernatants as positive control group, hVEGF siRNA A549 cell culture supernatants as hVEGF siRNA group and nonsilencing siRNA A549 cell culture supernatants as non-silencing siRNA group. The CAMs were harvested on d12 for microscopic assays.RESULT:Compared with control group, hVEGF siRNA-plasmid induced 48% reduction in hVEGF secretion by A549 cells accompanied by 70% reduction in hVEGF mRNA. Compared with non-silencing siRNA group, the mean tumor volume of murine xenograft was reduced by 58% in hVEGF siRNA group; time for xenografts growing to 50 mm(3)was delayed by 5.4 d. hVEGF contents in xenograft were reduced by 54%; but mean doubling time of tumors and the growth rate of tumors were not significantly reduced. In CAM assays, hVEGF content was zero in negative group, and in hVEGF siRNA group that was 40%-44% of non-silencing siRNA group or positive group; vessels branch points of CAM in hVEGF siRNA group or non-silencing siRNA group or positive group were increased by 45%-55% compared with negative group; total vessel length of CAM in hVEGF siRNA group was increased by 53% compared with negative group, while in non-silencing siRNA group or positive group that was increased by 97% or 99%. Compared with negative control group, the proliferation of microvessels was increased when cell culture supernatant with hVEGF was added in hVEGF siRNA group, significant proliferated vessels were observed in non-silencing siRNA group or positive group.CONCLUSION:A plasmid-mediated hVEGF siRNA has been constructed and verified, which can effectively downregulate the expression of hVEGF in human A549 cells, resulting in the inhibition of angiogenesis. hVEGF siRNA can delay initial growth of A549 tumor xenograft but not reduce the growth rate.

Influence of Specific Blocking of the Delta-Like Ligand 4/notch Signal Transduction Pathway on the Biological Behavior of Human Umbilical Vein Endothelial Cells

Directing Endothelial Differentiation of Human Embryonic Stem Cells Via Transduction with an Adenoviral Vector Expressing the VEGF165 Gene

Influence of Up-Regulation of Notch Ligand DLL4 on Biological Behaviors of Human Gastric Cancer Cells.

Study on Inhibitation of the Tube Formation by RNA Introduced by Adenovirus by its Interference With and Decrease of VEGF Transcription

The Effects of Microrna-34A Regulating Notch-1/NF-κB Signaling Pathway on Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells.

Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

Blocking of DLL4/Notch Signaling Deregulates Tumor Angiogenesis

Effect of GSK-3βtargeting RNAi Recombinant Adenovirus on Proliferation of Human Umbilical Vein Endothelial Cells

Modulating endothelial cell dynamics in fat grafting: the impact of DLL4 siRNA via adipose stem cell extracellular vesicles

[Inhibition of Proliferation and Migration of Human Umbilical Vein Endothelial Cells by Knockdown of Cylindromatosis (CYLD) Gene].

The Effect of the Knock-Down of the Ezrin Gene by Sirna on Proliferation of HUVECs

Spatial patterning of the Notch ligand Dll4 controls endothelial sprouting in vitro

Hepatocyte Nuclear Factor 4α Inhibits Expression of Vascular Endothelial Growth Factor in Human Hepatocellular Carcinoma Cell Lines and Tube Formation of Human Umbilical Vein Endothelial Cell

Adeno-associated virus type-2 expression of Kringle5 effect on HUC and Retinal cell of SD rat

Dll4 and Notch signalling couples sprouting angiogenesis and artery formation

Lentivirus-mediated RNA interference targeting STAT4 inhibits the proliferation of vascular smooth muscle cells.

The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs

Vascular Endothelial Growth Factor-A Inhibits Ephb4 and Stimulates Delta-Like Ligand 4 Expression in Adult Endothelial Cells

High FFA-induced proliferation and apoptosis in human umbilical vein endothelial cell partly through Wnt/β-catenin signal pathway

Upregulation of HAb18G/CD147 in Activated Human Umbilical Vein Endothelial Cells Enhances the Angiogenesis